https://www.siliconvalley.com/2020/03/26/coronavirus-who-gets-access-to-scarce-experimental-drug/

No one yet knows if a Bay Area medicine can help save the lives of coronavirus patients.

Yet demand is so high, and desperation so great, that Gilead Biosciences is tapping into its old stockpiles, scaling up manufacturing and announcing new rules for who gets access to its promising but unapproved drug.